List of Certificates of Suitability (CEPs) for r1_cep_2006_040___rev_06 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-040 - Rev 06 of Aarti Pharmalabs Limited Mulund (w), Mumbai In

score 20 · Accepted Answer

Aarti Pharmalabs Limited Mulund (w), Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

One of their significant offerings is Ramipril, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-040 - Rev 06

This Chemical Type CEP, issued on October 14, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1368 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for r1_cep_2006_040___rev_06 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Aarti Pharmalabs

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

8 CORPORATE CONTENT #SupplierSpotlight

1 DATA COMPILATION #PharmaFlow

41 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

INTERMEDIATES

KEY PRODUCTS

SERVICES

API Manufacturing

API & Drug Product Development

INSPECTIONS & REGISTRATIONS

Filters

R1-CEP 2006-040 - Rev 06

Valid

Chemical

2022-10-14

1368

01

Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-040 - Rev 06 of Aarti Pharmalabs Limited Mulund (w), Mumbai In